Latest filing published 22 Nov 2019 for Mereo BioPharma Group plc, €23k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +6.9%Entry US$2.18 · Close at T+365 US$2.33
- -76.9%Entry US$5.42 · Close at T+365 US$1.25
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Anders Ekblom: trading record in brief
Anders Ekblom appears in our data through filings on Mereo BioPharma Group plc shares, published by SEC (Form 4). In total, 4 filings cover trades dated from 7 May 2019 to 22 November 2019.
On the market, this insider has only ever bought: 2 purchases, €69k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 2 share grants.
The newest entry dates from 22 November 2019: an open-market purchase of €23k, in Mereo BioPharma Group plc. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Anders Ekblom
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$2.5433.5% of flowXNMSFCA-NSM:LSE20191122170953_14320409_20200326185146836_7768-0Canonical exit: 20 Feb 2020 (T+90)
- 5,500 sharesOutside of a trading venueFCA-NSM:LSE20190724100812_14161287_20200326185123408_10441-7
- 5,500 sharesOutside of a trading venueFCA-NSM:LSE20190521150839_14082298_20200326185142080_11482-7
- 9,340 shares@ US$5.46100.0% of flowXNMSFCA-NSM:LSE20190508135338_14066822_20200326185142896_23608Canonical exit: 5 Aug 2019 (T+90)
4 of 4 declarations
